Cencora, Inc Closed Now

Cencora, Inc., formerly known as AmerisourceBergen, is a leading global healthcare solutions company headquartered in Conshohocken, Pennsylvania. Created through a merger in 2001, the company officially adopted the new name “Cencora” on August 30, 2023, and trades on the NYSE under the ticker COR prnewswire.com+7Wikipedia+7Macrotrends+7.

Cencora specializes in pharmaceutical distribution, consulting services, and patient support operations. Its operations span multiple business units, including specialty and generic drug logistics, packaging, consulting support for healthcare providers, and global courier services through its acquisition of World Courier. The company handles around 20% of all pharmaceuticals distributed in the U.S., serving hospitals, pharmacies, clinics, nursing facilities, and other healthcare systems Wikipedia.

For fiscal year ending 2024, Cencora reported revenue of approximately US $294.0 billion, placing it among the top 10 U.S. companies on the 2025 Fortune 500 list, and likely among the top ~18 globally on the Fortune Global 500 list WikipediaWikipedia. While official Global 500 revenue rank is not always publicly broken down per company beyond top 10, collectively these firms generated record‑high revenue totals for fiscal 2024 globally prnewswire.comprnewswire.com.

Cencora employs approximately 46,000 people worldwide, with about 42,000 full-time staff as of September 30, 2024, and a workforce representing high diversity—around 51% of both employees and executive leadership identify as female and ~36% are U.S.-based SEC.

In January 2025, the company completed a significant acquisition of Retina Consultants of America (RCA)—a leading management services organization for retinal specialists—paying about US $4.4 billion for an 85% stake, expanding its reach in specialty healthcare services Reddit+1investor.amerisourcebergen.com+1.

Cencora is positioning itself for continued growth through strategic acquisitions, digital health investments, and expanded specialty distribution services. Fiscal year 2025 guidance reflects expected 7–9% revenue growth, 5–6.5% adjusted operating income growth, and aim to deliver adjusted diluted EPS of $14.80–15.10, though these projections exclude the full impact of the RCA acquisition investor.amerisourcebergen.com.